Validation for the function of protein C in mouse models

Ya Liu1, Maoping Cai1, Yan Chen1

  • 1Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, Guangdong, China.

Peerj
|April 29, 2024
PubMed
Abstract

Insights

Mice with a Protein C (PC) deficiency mutation showed altered blood clotting and organ damage, validating PC’s crucial role in anticoagulation and hemostasis.

Area of Science:

  • Biochemistry
  • Genetics
  • Hematology

Background:

  • Protein C (PC) is a vital anticoagulant protein encoded by the PROC gene.
  • Understanding PC's function is crucial for managing thrombotic and bleeding disorders.
  • Mouse models are essential for studying human genetic diseases.

Purpose of the Study:

  • To create and characterize a mouse model of autosomal recessive Protein C deficiency (PCD).
  • To investigate the in vivo function of Protein C using gene editing technology.
  • To validate the PROC c.1198G>A (p.Gly400Ser) mutation in a mammalian model.

Main Methods:

  • CRISPR/Cas9 gene editing was employed to introduce the specific PROC mutation in mice.
  • Genotyping, phenotypic analysis, and blood coagulation tests were performed on heterozygous and wild-type mice.
  • Histopathological examination (H&E staining) and immunohistochemistry were used to assess organ damage and fibrin deposition.

Main Results:

  • Heterozygous mice for the PC mutation exhibited prolonged clotting times (PT, APTT, TT) and decreased fibrinogen levels.
  • Reduced Protein C activity was observed in heterozygous mice, indicating impaired anticoagulant function.
  • Histopathology revealed liver steatosis, renal tubule damage, splenic hemorrhage, and significant fibrin deposition in multiple organs.

Conclusions:

  • The developed mouse model successfully recapitulates key features of Protein C deficiency.
  • The study validates the critical role of Protein C in maintaining hemostasis and preventing thrombosis.
  • The findings highlight the potential for organ damage secondary to PC deficiency.